Cue Biopharma, Inc. (CUE)
0.4868
-0.04
(-7.86%)
USD |
NASDAQ |
Dec 09, 16:00
0.4868
0.00 (0.00%)
After-Hours: 20:00
Cue Biopharma Total Liabilities (Quarterly): 18.40M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Insmed, Inc. | 1.415B |
| Puma Biotechnology, Inc. | 87.59M |
| Mersana Therapeutics, Inc. | 122.22M |
| Adaptive Biotechnologies Corp. | 286.36M |
| NovaBay Pharmaceuticals, Inc. | 1.853M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 31.64M |
| Shareholders Equity (Quarterly) | 13.25M |
| Debt to Equity Ratio | 0.466 |
| Current Ratio | 1.663 |
| Net Debt Paydown Yield | 1.82% |